Inflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody
Life Science Alliance · 2024
DOI: 10.26508/lsa.202402598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Ee-Soo Lee und 18 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Hauptthemen laut MEDLINE: Autoantibodies, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Healthcare Group, Ministry of Education - Singapore, NTU | Lee Kong Chian School of Medicine, Nanyang Technological University.
Abstract (Originalsprache)
Subclinical vascular impairment can be exacerbated in individuals who experience sustained inflammation after COVID-19 infection. Our study explores the prevalence and impact of autoantibodies on vascular dysfunction in healthy COVID-19 survivors, an area that remains inadequately investigated. Focusing on autoantibodies against the atypical chemokine receptor 1 (ACKR1), COVID-19 survivors demonstrated significantly elevated anti-ACKR1 autoantibodies, correlating with systemic cytokines, circulating damaged endothelial cells, and endothelial dysfunction. An independent cohort linked these autoantibodies to increased vascular disease outcomes during a median 6.7-yr follow-up. We analyzed a single-cell transcriptome atlas of endothelial cells from diverse mouse tissues, identifying enriched Ackr1 expressions in venous regions of the brain and soleus muscle vasculatures, which holds intriguing implications for tissue-specific venous thromboembolism manifestations reported in COVID-19. Functionally, purified immunoglobulin G (IgG) extracted from patient plasma did not trigger cell apoptosis or increase barrier permeability in human vein endothelial cells. Instead, plasma IgG enhanced antibody-dependent cellular cytotoxicity mediated by patient PBMCs, a phenomenon alleviated by blocking peptide or liposome ACKR1 recombinant protein. The blocking peptide uncovered that purified IgG from COVID-19 survivors possessed potential epitopes in the N-terminal extracellular domain of ACKR1, which effectively averted antibody-dependent cellular cytotoxicity. Our findings offer insights into therapeutic development to mitigate autoantibody reactivity in blood vessels in chronic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
- National Centre for Infectious Diseases, Singapore, Singapore.
- Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Singapore.
- Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.
ORCID-Profile: Ee-Soo Lee, Nhi Nguyen, Khang Leng Lee, Michelle Cy Law, Lay Teng Ang, Mark Y Chan, Bingwen E Fan, Laurent Renia, Christine Cheung
Förderung
- National Healthcare Group
- Ministry of Education - Singapore
- NTU | Lee Kong Chian School of Medicine, Nanyang Technological University
- National Health Innovation Centre Singapore
- Human Frontier Science Program
- Additional Ventures
- Thomas and Stacey Siebel Foundation
Zitieren
APA
Lee, E. S., Nguyen, N., Young, B. E., Wee, H., Wazny, V., Lee, K. L., Tay, K. Y., Goh, L. L., Chioh, F. W., Law, M. C., Lee, I. R., Ang, L. T., Loh, K. M., Chan, M. Y., Fan, B. E., Dalan, R., Lye, D. C., Renia, L., & Cheung, C. (2024). Inflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody. Life Science Alliance. https://doi.org/10.26508/lsa.202402598
Vancouver
Lee ES, Nguyen N, Young BE, Wee H, Wazny V, Lee KL, et al. Inflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody. Life Science Alliance. 2024. doi:10.26508/lsa.202402598
BibTeX
@article{Lee2024,
author = {Lee, Ee-Soo and Nguyen, Nhi and Young, Barnaby E and Wee, Hannah and Wazny, Vanessa and Lee, Khang Leng and Tay, Kai Yi and Goh, Liuh Ling and Chioh, Florence Wj and Law, Michelle Cy and Lee, I Russel and Ang, Lay Teng and Loh, Kyle M and Chan, Mark Y and Fan, Bingwen E and Dalan, Rinkoo and Lye, David C and Renia, Laurent and Cheung, Christine},
title = {Inflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202402598}
}
EUVIMED